Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02928848 · ClinicalTrials.gov registry record · NA
Transcranial Direct Current Stimulation for Primary Progressive Aphasia
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT02928848: Completed NA study, sponsored by University of Pennsylvania.
NCT02928848 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02928848, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
In the present sham-controlled study, the investigators examine whether tDCS could be used to enhance language abilities (e.g., picture naming) in individuals with primary progressive aphasia (PPA) primarily characterized by difficulties with speech production.
Interventions
- DEVICE transcranial direct current stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-06-16 |
| Est. Completion | 2020-03-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02928848
The ClinicalTrials.gov registry entry for NCT02928848 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which transcranial direct current stimulation is the first listed.
NCT02928848 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02928848 about?
NCT02928848 is a clinical study titled "Transcranial Direct Current Stimulation for Primary Progressive Aphasia". In the present sham-controlled study, the investigators examine whether tDCS could be used to enhance language abilities (e.g., picture naming) in individuals with primary progressive aphasia (PPA) primarily characterized by difficulties with speech production.
What is the current status of trial NCT02928848?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2017-06-16. Estimated completion is 2020-03-13.
What interventions are being tested in trial NCT02928848?
The interventions under investigation include: transcranial direct current stimulation (DEVICE).
Who is sponsoring clinical trial NCT02928848?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.